Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 2
2005 3
2007 2
2008 2
2009 4
2010 1
2011 1
2012 3
2013 2
2014 3
2016 6
2017 2
2019 1
2020 3
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Coagulation and anticoagulation in COVID-19.
Hadid T, Kafri Z, Al-Katib A. Hadid T, et al. Among authors: al katib a. Blood Rev. 2021 May;47:100761. doi: 10.1016/j.blre.2020.100761. Epub 2020 Oct 8. Blood Rev. 2021. PMID: 33067035 Free PMC article. Review.
Hematologic malignancies: newer strategies to counter the BCL-2 protein.
Ebrahim AS, Sabbagh H, Liddane A, Raufi A, Kandouz M, Al-Katib A. Ebrahim AS, et al. Among authors: al katib a. J Cancer Res Clin Oncol. 2016 Sep;142(9):2013-22. doi: 10.1007/s00432-016-2144-1. Epub 2016 Apr 4. J Cancer Res Clin Oncol. 2016. PMID: 27043233 Review.
Targeting CD19 in B-cell lymphoma: emerging role of SAR3419.
Raufi A, Ebrahim AS, Al-Katib A. Raufi A, et al. Among authors: al katib a. Cancer Manag Res. 2013 Aug 27;5:225-33. doi: 10.2147/CMAR.S45957. eCollection 2013. Cancer Manag Res. 2013. PMID: 24023523 Free PMC article. Review.
New targets for the treatment of follicular lymphoma.
Tageja N, Padheye S, Dandawate P, Al-Katib A, Mohammad RM. Tageja N, et al. Among authors: al katib a. J Hematol Oncol. 2009 Dec 23;2:50. doi: 10.1186/1756-8722-2-50. J Hematol Oncol. 2009. PMID: 20030851 Free PMC article. Review.
Unintended target effect of anti-BCL-2 DNAi.
Ebrahim AS, Kandouz M, Emara N, Sugalski AB, Lipovich L, Al-Katib AM. Ebrahim AS, et al. Among authors: al katib am. Cancer Manag Res. 2017 Sep 22;9:427-432. doi: 10.2147/CMAR.S139105. eCollection 2017. Cancer Manag Res. 2017. PMID: 28989285 Free PMC article.
Composite Lymphoma: Opposite Ends of Spectrum Meet.
Khan U, Hadid T, Ibrar W, Sano D, Al-Katib A. Khan U, et al. Among authors: al katib a. J Clin Med Res. 2017 Mar;9(3):213-215. doi: 10.14740/jocmr2929w. Epub 2017 Jan 25. J Clin Med Res. 2017. PMID: 28179969 Free PMC article.
Isolation and characterization of a CD34+ sub-clone in B-cell lymphoma.
Al-Katib AM, Ebrahim AS, Kandouz M, Zaiem F, Raufi A, Ebrahim S, Mohamed A, Emara N, Gabali AM. Al-Katib AM, et al. Oncotarget. 2020 Jan 14;11(2):148-160. doi: 10.18632/oncotarget.27415. eCollection 2020 Jan 14. Oncotarget. 2020. PMID: 32010428 Free PMC article.
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Westin J, Maris MB, Jacobson CA, Patel P, Lakhani N, Harb W, Patel-Donnelly D, McCaul K, Escobar C, Klencke B, Al-Katib AM. Westin J, et al. Among authors: al katib am. Clin Lymphoma Myeloma Leuk. 2022 Jan;22(1):52-59. doi: 10.1016/j.clml.2021.07.020. Epub 2021 Jul 25. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34454850 Clinical Trial.
48 results